GIDARI, ANNA
 Distribuzione geografica
Continente #
NA - Nord America 726
AS - Asia 555
EU - Europa 514
SA - Sud America 102
AF - Africa 8
OC - Oceania 3
Totale 1.908
Nazione #
US - Stati Uniti d'America 706
SG - Singapore 293
IT - Italia 207
HK - Hong Kong 95
BR - Brasile 90
IE - Irlanda 90
CN - Cina 70
DE - Germania 56
RU - Federazione Russa 42
KR - Corea 37
FI - Finlandia 29
VN - Vietnam 25
GB - Regno Unito 21
AT - Austria 13
FR - Francia 12
CA - Canada 10
IN - India 9
MX - Messico 9
LT - Lituania 6
NL - Olanda 6
PL - Polonia 6
ID - Indonesia 5
JP - Giappone 5
AR - Argentina 4
BE - Belgio 4
CZ - Repubblica Ceca 4
SE - Svezia 4
UA - Ucraina 4
ZA - Sudafrica 4
ES - Italia 3
AU - Australia 2
CH - Svizzera 2
EC - Ecuador 2
PK - Pakistan 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BD - Bangladesh 1
BH - Bahrain 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
GF - Guiana Francese 1
GR - Grecia 1
IL - Israele 1
IQ - Iraq 1
KG - Kirghizistan 1
KW - Kuwait 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MA - Marocco 1
MD - Moldavia 1
MR - Mauritania 1
PE - Perù 1
PY - Paraguay 1
RO - Romania 1
SN - Senegal 1
TH - Thailandia 1
UZ - Uzbekistan 1
VE - Venezuela 1
WS - Samoa 1
Totale 1.908
Città #
Singapore 206
Perugia 108
Chandler 99
Hong Kong 95
Dublin 90
Ashburn 64
Boardman 39
Seoul 36
Los Angeles 33
Munich 33
Santa Clara 33
New York 24
Columbus 22
San Mateo 20
Redmond 19
Turku 18
Wilmington 17
Moscow 15
Altamura 13
Piscataway 13
Medford 12
Princeton 12
Ho Chi Minh City 11
Lawrence 11
São Paulo 11
Dallas 9
Milan 9
Poplar 9
Ann Arbor 8
Bastia umbra 8
Bologna 8
Florence 8
Hanoi 8
Nuremberg 8
Rome 8
The Dalles 8
Beijing 7
Helsinki 7
Montreal 6
Vienna 6
Warsaw 6
Chennai 5
Falkenstein 5
Hefei 5
Mexico City 5
Padova 5
Paris 5
Tokyo 5
Andover 4
Boston 4
Brooklyn 4
Brussels 4
Denver 4
Lappeenranta 4
Atlanta 3
Belo Horizonte 3
Den Haag 3
Des Moines 3
Frankfurt am Main 3
Houston 3
London 3
Manchester 3
Mumbai 3
Phoenix 3
Querétaro 3
Seattle 3
Stockholm 3
Tappahannock 3
Toronto 3
Ankara 2
Chengdu 2
Chicago 2
Falls Church 2
Guangzhou 2
Juiz de Fora 2
Madrid 2
Manaus 2
Naples 2
Oklahoma City 2
Olomouc 2
Orem 2
Porto Alegre 2
Recife 2
Rio de Janeiro 2
San Jose 2
Santos 2
Sinalunga 2
St Petersburg 2
Vicenza 2
Vilnius 2
West Jordan 2
Woodbridge 2
Alcamo 1
Amsterdam 1
Anguillara Sabazia 1
Annapolis 1
Apia 1
Arantina 1
Araruama 1
Araucária 1
Totale 1.335
Nome #
SARS-CoV2 infection impairs the metabolism and redox function of cellular glutathione 130
Predictive value of National Early Warning Score 2 (NEWS2) for intensive care unit admission in patients with SARS-CoV-2 infection 121
Cross-neutralization of SARS-CoV-2 B.1.1.7 and P.1 variants in vaccinated, convalescent and P.1 infected 98
Impact of SARS-CoV-2 Omicron variants on serum neutralization in a cohort of healthcare workers vaccinated with BNT162b2 94
Is recurrence possible in coronavirus disease 2019 (COVID-19)? Case series and systematic review of literature 94
SARS-CoV-2 Survival on Surfaces and the Effect of UV-C Light 91
Discovery of a AHR pelargonidin agonist that counter-regulates Ace2 expression and attenuates ACE2-SARS-CoV-2 interaction 87
Role of nucleocapsid protein antigen detection for safe end of isolation of sars-cov-2 infected patients with long persistence of viral rna in respiratory samples 83
Predictive risk factors for worse outcomes in COVID-19 patients with different clinical features at baseline 78
Pre and Post-Monoclonal Infusion Neutralizing Activity in a Subgroup of Patients Treated in the Presence of two SARS-CoV-2 Dominant Variant of Concern (VOCs) and an Ongoing Vaccination. Overall Clinical Efficacy of Two Monoclonal Antibodies Association in Umbria 76
National Early Warning Score 2 (NEWS2) better predicts critical Coronavirus Disease 2019 (COVID-19) illness than COVID-GRAM, a multi-centre study 75
Low brachial artery flow-mediated dilation predicts worse prognosis in hospitalized patients with covid-19 75
Comorbidities, cardiovascular therapies, and COVID-19 mortality: A nationwide, italian observational study (ItaliCO) 70
The Combination of Molnupiravir with Nirmatrelvir or GC376 Has a Synergic Role in the Inhibition of SARS-CoV-2 Replication In Vitro 66
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients 66
BNT162b2 Elicited an Efficient Humoral Response Against Different Strains of SARS-CoV-2 in People Living with HIV 62
Bictegravir/Tenofovir Alafenamide/Emtricitabine: A Real-Life Experience in People Living with HIV (PLWH) 56
Protective Effect of Indole-3-Aldehyde in Murine COVID-19-Associated Pulmonary Aspergillosis 54
Nelfinavir: An Old Ally in the COVID-19 Fight? 54
Tixagevimab/Cilgavimab: Still a Valid Prophylaxis against COVID-19 New Variants? 54
Stabilization of the Dimeric State of SARS-CoV-2 Main Protease by GC376 and Nirmatrelvir 54
Efficacy of Licensed Monoclonal Antibodies and Antiviral Agents against the SARS-CoV-2 Omicron Sublineages BA.1 and BA.2 53
Tedizolid-Rifampicin Combination Prevents Rifampicin-Resistance on in vitro Model of Staphylococcus aureus Mature Biofilm 53
Dolutegravir/Lamivudine versus Tenofovir Alafenamide/Emtricitabine/Bictegravir as a Switch Strategy in a Real-Life Cohort of Virogically Suppressed People Living with HIV 49
Chronic antibiotic suppressive therapy with dalbavancin: a case series 46
The hope and hype of ellagic acid and urolithins as ligands of SARS-CoV-2 Nsp5 and inhibitors of viral replication 46
Synergistic Activity of Remdesivir–Nirmatrelvir Combination on a SARS-CoV-2 In Vitro Model and a Case Report 45
Effectiveness, safety and tolerability of dolutegravir/lamivudine versus tenofovir alafenamide/emtricitabine/bictegravir in a real-life cohort of HIV-1 virologically suppressed treatment experienced people living with HIV 38
Use of a molecular syndromic panel for the etiological diagnosis of ventilator-associated bacterial pneumonia: impact on clinical outcomes and antibiotic use from a multicenter, prospective study 30
Totale 1.998
Categoria #
all - tutte 10.253
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.253


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202145 0 0 0 0 0 3 1 2 2 19 1 17
2021/2022108 6 19 3 2 4 5 1 17 7 6 24 14
2022/2023328 12 45 5 49 29 26 3 15 122 0 17 5
2023/2024184 7 21 5 2 4 4 57 1 12 11 30 30
2024/2025664 15 42 19 32 35 46 92 65 102 58 97 61
2025/2026643 71 89 63 199 186 35 0 0 0 0 0 0
Totale 1.998